HMOX1 and urinary bladder carcinoma: In the present study, our results demonstrated that CAPE treatment upregulated MT2A and HO-1 expressions to alleviate endogenous ROS in bladder carcinoma cells which is consistent with other studies in HL-60 and H9c2 cells [36,37].